China Biopharma Expansion Attracts Global Capital as Innovation Accelerates

China’s biotechnology sector is entering a new phase of financial maturity as companies move beyond heavy reliance on licensing agreements and tap deeper pools of domestic and international capital. Strong equity market performance, regulatory reforms and expanding innovation pipelines are reshaping the funding

BeOne Medicines Elevates R&D Leader Wang Lai to Co President to Drive Global Growth

BeOne Medicines has taken a significant step in reshaping its leadership structure as it accelerates global expansion and advances its late stage drug pipeline. The company announced that Wang Lai, its long serving head of research and development, has been promoted to the